Companies: 10,795·Total market cap: $144.5T
MeiraGTx Holdings plc

MeiraGTx Holdings plc

MGTXNASDAQHealthcare● Active
$9.06
+$0.06(+0.67%)
Market Cap$839042070
P/E Ratio
52W High$11.85
52W Low$5.235

MeiraGTx Holdings plc (MGTX) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · MGTX · as of Mar 31, 2025

Ownership Breakdown

Institutions 64.77%
Insiders 24.29%
Public 10.94%

121

Institutional Holders

▲ 17 vs Q4

$406.66M

Total Inst. Value

▲ $52.77M vs Q4

92.61M

Shares Outstanding

freeFloat 75.71%

59.99M

13F Shares Held

▲ 1.85M vs Q4

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

MGTX largest shareholders · institutional ownership

Q1 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

PERCEPTIVE ADVISORS LLC

biological products, (no diagnostic substances)

12.58M15.92%

15.92%

$85.25BAug 6, 2025— held

SANOFI

biological products, (no diagnostic substances)

12.20M15.43%

15.43%

$82.70BMay 6, 2025— held

JOHNSON & JOHNSON

biological products, (no diagnostic substances)

6.64M8.40%

8.40%

$45.03BMay 7, 2025— held

ADAGE CAPITAL PARTNERS GP, L.L.C.

biological products, (no diagnostic substances)

5.63M7.13%

7.13%

$38.20BMay 15, 2025 600.0K

PROSIGHT MANAGEMENT, LP

biological products, (no diagnostic substances)

3.69M4.67%

4.67%

$25.03BMay 15, 2025 699.3K

BLACKROCK, INC.

biological products, (no diagnostic substances)

3.13M3.96%

3.96%

$21.21BMay 2, 2025 156.9K

683 CAPITAL MANAGEMENT, LLC

biological products, (no diagnostic substances)

2.58M3.26%

3.26%

$17.46BMay 15, 2025 160.0K

RUBRIC CAPITAL MANAGEMENT LP

biological products, (no diagnostic substances)

1.78M2.25%

2.25%

$12.04BMay 14, 2025NEW

KNOLL CAPITAL MANAGEMENT, LLC

biological products, (no diagnostic substances)

1.25M1.58%

1.58%

$8.47BMay 15, 2025— held

J. GOLDMAN & CO LP

biological products, (no diagnostic substances)

1.16M1.47%

1.47%

$7.86BMay 15, 2025 608.2K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q1 2025 vs prior quarter

Q1 2025

Net institutional sentimentBullish — more buying than selling

20

Increased

+2.49M shares

5

New Positions

first time holders

18

Decreased

−2.33M shares

0

Sold Out

fully exited

Net shares change (top 50)

+167.8K

+2.49M / −2.33M

Net new holders

+7

5 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

MGTX insider trading · insider activity

Source: SEC Form 4

Buy 0%Active transactions only100% Sell

Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.

3

Buy transactions

4

Sell transactions

0.75

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Giroux Richard

CFO & COO

May 27, 2026Gift7,000964.5KForm 4 ↗

Forbes Alexandria

PRESIDENT & CEO

May 19, 2026Sale62,000$9.17$568.5K1.39MForm 4 ↗

Fleck Penny Renee

CHIEF DEVELOPMENT OFFICER

May 13, 2026Award100,000$9.97$997.0K100.0KForm 4 ↗

Fleck Penny Renee

CHIEF DEVELOPMENT OFFICER

May 13, 2026Award100,000100.0KForm 4 ↗

Zeldin Robert K

CHIEF MEDICAL OFFICER

Jan 7, 2026Tax Withhold7,814$7.73$60.4K146.2KForm 4 ↗

PERCEPTIVE ADVISORS LLC

Apr 17, 2026Award555,555$9.00$5.00M10.79MForm 4 ↗

PERCEPTIVE ADVISORS LLC

Aug 2, 2022Award400,000$15.00$6.00M400.0KForm 4 ↗

PERCEPTIVE ADVISORS LLC

Mar 25, 2026Award400,000$8.00$3.20M400.0KForm 4 ↗

PERCEPTIVE ADVISORS LLC

Aug 2, 2022Award300,000$20.00$6.00M300.0KForm 4 ↗

PERCEPTIVE ADVISORS LLC

Mar 25, 2026Award300,000$8.00$2.40M300.0KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

MeiraGTx Holdings plc (MGTX) is primarily owned by institutional investors, who hold approximately 64.8% of total shares outstanding. Company insiders own approximately 24.29%, while retail and public investors account for the remaining 10.94%.

The largest institutional shareholder of MeiraGTx Holdings plc is PERCEPTIVE ADVISORS LLC, holding approximately 12.58 million shares — equal to 15.92% of outstanding shares — as of March 31, 2025.

A total of 121 institutional investors currently hold MGTX stock, with a combined institutional value of approximately $406,655,065 as of the most recent 13F filing period.

Frequently asked questions

MGTX ownership

MeiraGTx Holdings plc (MGTX) is primarily owned by institutional investors, who hold approximately 64.8% of shares. The largest shareholder is PERCEPTIVE ADVISORS LLC with a 15.92% stake. Company insiders hold 24.29%. Data sourced from SEC Form 13F as of March 31, 2025.

who owns MGTX stockMGTX ownership structureSEC Form 13F institutional holdingsMGTX float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of March 31, 2025